News

Tjoapack invests in blistering capabilities

Hannah Alderton 10 May 2018

Global contract packaging organisation (CPO), Tjoapack has invested in its blistering capacity, adding a new line that will be equipped with late-stage customisation printing capabilities.

Expected to be operational by the end of Q3 2018, the new line, at the company’s facility in Etten-Leur, Netherlands, will take its total number of blistering lines to eight.

The investment will also expand Tjoapack’s current postponement printing offering, enabling the CPO to offer drop-on-demand digital printing for blisters.  

Founded in 1989, Tjoapack is an independent contract packager of medicines servicing clients across five continents and 42 countries.

The CPO specialises in primary packaging for solid dosage forms, secondary packaging and unit dose packaging and now has a total of 19 packaging lines for blisters, wallets and bottles. Using these lines, it packages around 26 million packs of pharmaceutical products per year, which equates to around 1.4 billion tablets.

 “Late-stage customisation, or postponement printing, is something that is presenting some interesting benefits for the pharmaceutical supply chain. The process of only making packaging market-specific once there is a demand could be hugely beneficial in terms of reducing waste from repackaging, overall costs and time to market.

Make a comment

To voice your opinion, please Log in or Register.

Pf Magazine

Your resource for news, features, interviews, careers and events in the pharma industry.

Click here for the latest issue and to subscribe.